This report provides exclusive insights into the COVID-19 impact on the Label-free Array Systems Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Label-free Array Systems Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Label-free Array Systems Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on label-free array systems market provides in-depth
analysis of segments and sub-segments in the global as well as regional
label-free array systems market. The study also highlights the impact of
drivers, restraints, and macro indicators on the global and regional label-free
array systems market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of the global
label-free array systems market. According to the report, the global label-free
array systems market is projected to grow at a CAGR of 7.2% over the forecast
period of 2019-2025.
Market Insight
Label-free array systems are used
in the drug discovery process by the biotechnology and pharmaceutical
companies. It is used to identify and validate new molecules as possible drug
candidates. It works on the principle of refractive index, optical
interferometry, and impedance-based assays. Companies operating in the global
label-free array systems market are adopting strategies such as mergers,
acquisitions, and new product launches that expand their market share.
The increasing investments in
surface plasmon resonance technology due to real-time monitoring of
biomolecules and its ability to handle crude samples stimulate the growth of
the label-free array systems market. The rising demand for advanced systems
that achieve productive drug discovery processes drives the growth of the
label-free array systems market. The increasing adoption of label-free array
systems in the pharmaceutical and biotechnology industries contributes to the
growth of the label-free array systems market. In addition, growing investments
in research and development for drug discovery promotes the growth of the
label-free array systems market. On the other side, the high cost of label-free
array systems hamper the growth of the label-free array systems market.
Moreover, increasing investments by pharmaceutical companies in research and
development create novel opportunities for the growth of the label-free array
systems market.
Based on geography, the global
label-free array systems market is classified into North America, Asia-Pacific,
Europe, and the Rest of the World. North America is anticipated to have a premium
share in the global label-free array systems market. The growing adoption of
technologically advanced label-free array systems in North America drives the
growth of the label-free array systems market in North America. Europe is
expected to grow in the global label-free array systems market with a healthy
CAGR over the forecast period of 2019-2025. The surge in the number of
biotechnology companies focused on research and development in Europe promotes
the growth of the label-free array systems market in Europe. Asia-Pacific
region is showing growth in the global label-free array systems market due to
the rising adoption of label-free array methods in drug discovery
processes.
Segment Covered
The report on global label-free
array systems market covers segments such as technique, application, and
end-user. On the basis of technique, the sub-markets include microcantilever,
surface plasmon resonance, enthalpy array, scanning kelvin nanoprobe, atomic
force microscopy, ellipsometry techniques, and other techniques. On the basis
of application, the sub-markets include biomolecular interactions, drug
discovery, detection of disease biomarkers, and other applications. On the
basis of end-user, the sub-markets include contract research organizations,
academic and research institutes, pharmaceuticals and biotechnology industries,
and other end-users.
Companies Profiled:
The report provides profiles of
the companies in the market such as F. Hoffmann-La-Roche AG, GE Healthcare,
Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc.,
PerkinElmer, Inc., BiOptix, Inc., Attana AB, GWC Technologies Inc., Molecular
Devices, LLC, and other companies.
Report Highlights:
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of label-free array systems market. Moreover, the study highlights
current market trends and provides forecast from 2019-2025. We also have
highlighted future trends in the market that will affect the demand during the
forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.